E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches

• Autorzy: Rodo A. , Malicka E.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to investigate E-cadherin expression in correlation with other neoplasm traits such as: histological type, the differentiation grade and proliferative activity. Material for the investigation comprised mammary gland tumours, collected from dogs, the patients of veterinary clinics, during surgical procedures and archival samples. All together 21 adenomas, 32 complex carcinomas, 35 simple carcinomas and 13 solid carcinomas were qualified for further investigation. E-cadherin expression was higher in adenomas as compared with carcinomas but lower in solid carcinomas as compared with simple and complex carcinomas. More over, the expression of E-cadherin decreased with the increase in the neoplasm malignancy and proliferative activity (value of the mitotic index and number of cells showing Ki67). The study has shown that the expression of E-cadherin can be used as a prognostic factor.

Słowa kluczowe

EN

dog; bitch; mammary gland; cancer; E-cadherin; immunohistochemistry; E-cadherin expression; proliferative activity; tumour; carcinoma; prognostic factor

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2008
• Tom: 11
• Numer: 1
• Opis fizyczny: p.47-54,fig.,ref

Twórcy

autor

Rodo A.

• Warsaw University of Life Sciences, Nowoursynowska 159C, 02-766 Warsaw, Poland

autor

Malicka E.

Bibliografia

• Asgeirsson KS, Jonassom JG, Tryggvadottir L, Olafsdottir K, Sigurgeirsdottir JR, Ingvarsson S, Ogmundstottir HM (2000) Altered expression of E-cadherin in breast cancer: patterns, mechanisms and clinical significance. Eur J Cancer 36: 1098-1106.
• Benjamin SA, Lee AC, Saunders WJ (1999) Classification and behaviour of canine mammary epithelial neoplasms based on life-span observation in beagles. Vet Pathol 36: 423-436.
• Brunetti B, Sarli G, Preziosi I, Monari I, Benazzi C (2005) E-cadherin and (l-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors. Vet Pathol 42: 781-787.
• Brunetti B, Sarli G, Preziosi R, Leprotti S, Benazzi C (2003) E-cadherin expression in canine mammary carcinoma with regional lymph node métastasés. J Vet Med 50: 496-500.
• Charbin C, Bonnier P, Garcia S, Andrac L, Crebassa B, Dorel M, Lavaut MN, Allasia C (1999) E-cadherin and (i-catenin expression in breast medullary carcinomas. Int J Oncol 15: 285-292.
• Cowin P, Rowlands TM, Hatsell SJ (2005) Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17: 499-508.
• St. Croix B, Sheehan C, Rak JW, Flrrenes VA, Slingerland JM, Kerbel RS (1998) E-cadherin- dependent growth suppression is mediated by the cyclin- dependent kinase inhibitor p27 KIP1. J Cell Biol 142: 557-571.
• McEntee MF, Brenneman KA (1999) Dysrégulation of (l-catenin is common in canine sporadic colorectal tu­mors. Vet Pathol 36: 228-236.
• Fricke E, Keller G, Becker I, Rosinatz E, Schott C, Plaschke S, Rudelius M, Hermannstadter C, Busch R, Hofler H, Becker KF, Luber B (2003) Relationship between E-cad- herin gene mutation and p53 gene mutation, p53 accu­mulation, Bcl-2 expression and Ki-67 staining in diffuse- type gastric carcinoma. Int J Cancer 104: 60-65.
• Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lohner D, Birchmeier W (1991) E-cadherin mediated cell-cell adhesion prevents invasiveness of human car­cinoma cells. J Cell Biol 113: 173-185.
• Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N, Doi K (2000) Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol 37: 177-183.
• Gilbertson S, Kurzman I, Zachrau R, Hurritz A, Black M (1983) Canine mammary epithelial neoplasms: bio­logic implication of morphologic characteristics assessed in 232 dogs. Vet Pathol 20: 127-142.
• Goldstein NS, Kestin LL, Vicini FA (2001) Clini- copathologic implications of E cadherin reactivity in pa­tients with lobular carcinoma in situ of the breast. Cancer 92: 738-747.
• Lee JL, Chang CJ, Wu SY, Sargan DR, Lin CT (2004) Se­creted frizzled- related protein 2 (SFRP2) is highly ex­pressed in canine mammary gland tumors but not in nor­mal glands. Breast Cancer Res Treat 84: 139-149.
• Lôhr CV, Teifke JP, Failing K, Weiss E (1997) Characteriz­ation the standarized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol 34: 212-221.
• Malicka E, Piusiński W, Sendecka H, Bielecki W, Osińska B, Lenartowicz-Kubrat Z (1996) Nowotwory psów stwier­dzane w badaniach anatomopatologicznych w latach 1985-1993. Med Weter 2: 103-106.
• Misdorp W (2002) Tumors of the mammary gland. In: Meuten DJ (ed) Tumors in domestic animals. Iowa State Press, pp 575-606.
• Misdorp W, Else RW, Hellmen E, Lipscomb T.P (1999) Histological classification of mammary tumors of the dog and cat, Bulletin of the World Health (Organization, Geneva.
• Menon MM, Simha MM (1998) Cell adhesion molecule E-cadherin and cellular proliferation marker AgNOR in bladder lesions- usefulness and limitations. Int J Cancer 35: 142-146.
• Moulton JE (1990) Tumors of the mammary gland. In: Moulton JE (ed) Tumors in domestic animals, University of California Press, pp 518-552.
• Muías JM, Millhn Y, Dios R (2005) A prospective analysis of immunohistochemically determined estrogen receptor a and progesterone receptor expression and host and tu­mor factors as predictors of disease- free period in mam­mary tumors of the dog. Vet Pathol 42: 200-212.
• Nieto A, Pena L, Pérez- Alenza MD, Sánchez MA, Flores JM, Castaño M (2000) Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: cli­nical and pathologic associations and prognostic signifi­cance. Vet Pathol 37: 239-247.
• Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW, Waters DJ (2003) Influence of host factors on sur­vival in dogs with malignant mammary gland tumors. J Vet Intern Med 17: 102-106.
• Pena LL, Nieto AI, Perez-Alenza D (1998) Immunohis- tochemical detection of Ki-67 and PCNA in canine mam­mary tumors: Relationship to clinical and pathologic vari­ables. J Vet Diagn Invest 10: 237-246.
• Reis AL, Carvalheira J, Schmitt FC, Gartner F (2003) Im- munohistochemical study of the expression of E-cadherin in canine mammary tumours. Vet Rec 152: 621-624.
• Reis- Filho (2002) Clinicopathologic implications of E-cad­herin reactivity with lobular carcinoma in situ of the breast. Cancer 94: 2114-2115.
• Rodo A (2007) Ekspresja receptora HER-2, kadheryny E oraz białka p53 w nowotworach gruczołu sutkowego suk. Doctoral thesis. SGGW, Warszawa.
• Sarli G, Preziosi R, De Tolla L, Brunetti B, Benazzi C (2004) E-cadherin immunoreactivity in canine mam­mary tissues. J Vet Diagn Invest 16: 542-547.
• Szczubiał M, Łopuszyński W (2002) Rokowanie w nowot­worach gruczołu mlekowego suk. Med Weter 58: 261- -264.
• Torres LN, Matera JM, Vasconcellos CH, Avanzo JL, Her- nandez-Blazquez EJ, Daglo ML (2005) Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands. Vet Pathol 42: 633-641.